This bill establishes a commission to recommend fair prescription drug prices, enforced by civil penalties. Violating fair pricing laws will be treated as unfair trade practices, and the Federal Trade Commission and states will enforce these laws. It also enables the government to claim licenses from patent owners who sell drugs above fair prices or fail to meet patient demand. Additionally, it authorizes the President to use the Defense Production Act to boost domestic drug supply if foreign supply cannot meet demand at a fair price. The bill aims to regulate drug prices, increase domestic production, and impact drug availability and affordability for U.S. consumers.